Telo Genomics Corp.
TELO.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 167.90K | 165.00K | 202.60K | 204.30K | 350.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 454.20K | 404.40K | 437.10K | 456.90K | 613.90K |
| Operating Income | -454.20K | -404.40K | -437.10K | -456.90K | -613.90K |
| Income Before Tax | -438.80K | -405.30K | -437.90K | -449.50K | -613.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -438.80K | -405.30K | -437.90K | -449.50K | -613.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -438.80K | -405.30K | -437.90K | -449.50K | -613.90K |
| EBIT | -454.20K | -404.40K | -437.10K | -456.90K | -613.90K |
| EBITDA | -451.90K | -400.50K | -430.70K | -449.60K | -606.10K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 76.77M | 74.56M | 71.61M | 71.31M | 71.31M |
| Average Diluted Shares Outstanding | 76.77M | 74.56M | 71.61M | 71.31M | 71.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
